Skip to main content
. 2015 Mar 27;18(1):16–21. doi: 10.4048/jbc.2015.18.1.16

Table 1.

Prechemotherapy clinicopathological characteristics

Characteristic Low p53 No. (%) High p53 No. (%) p-value Low Ki-67 No. (%) High Ki-67 No. (%) p-value Bcl-2 (-) No. (%) Bcl-2 (+) No. (%) p-value
Age (yr)* 41.9 ± 9.9 43.6 ± 9.8 0.319 43.6 ± 10.4 42.9 ± 9.8 0.705 44.1 ± 9.9 41.4 ± 9.5 0.115
Initial tumor size (cm) 0.32 0.26 0.571
 <3 20 (22.7) 34 (31.8) 7 (20.6) 46 (28.9) 35 (29.9) 20 (25.6)
 3-5 37 (42.0) 43 (40.2) 14 (41.2) 65 (40.9) 46 (39.3) 33 (42.3)
 > 5 31 (35.2) 30 (28.0) 13 (38.2) 48 (30.2) 36 (30.8) 25 (32.1)
 Continuous 4.5 ± 1.8 4.4 ± 2.0 0.521 4.7 ± 2.2 4.3 ± 1.8 0.523 4.5 ± 2.0 4.3 ± 1.7 0.529
Initial N stage 0.662 0.528 0.547
 N0 3 (3.4) 2 (1.9) 2 (5.9) 3 (1.9) 3 (2.6) 2 (2.6)
 N1 44 (50.0) 63 (58.9) 17 (50.0) 89 (56.0) 63 (53.8) 44 (56.4)
 N2 30 (34.1) 25 (23.4) 9 (26.5) 45 (28.3) 33 (28.2) 22 (28.2)
 N3 11 (12.5) 17 (15.9) 6 (17.6) 22 (13.8) 18 (15.4) 10 (12.8)
Initial c stage 0.382 0.875 0.429
 IIA 5 (5.7) 3 (2.8) 1 (2.9) 7 (4.4) 3 (2.6) 5 (6.4)
 IIB 25 (28.4) 37 (34.6) 12 (35.3) 49 (30.8) 38 (32.5) 24 (30.8)
 IIIA 37 (42.0) 40 (37.4) 11 (32.4) 65 (40.9) 46 (39.3) 31 (39.7)
 IIIB 9 (10.2) 9 (8.4) 4 (11.8) 14 (8.8) 11 (9.4) 7 (9.0)
 IIIC 12 (13.6) 18 (16.8) 6 (17.6) 24 (15.1) 19 (16.2) 11 (14.1)
Histology 0.15 0.285 0.468
 Ductal 83 (94.3) 106 (99.1) 32 (94.1) 155 (97.1) 112 (95.7) 77 (98.7)
 Others 5 (5.7) 1 (0.9) 2 (5.9) 4 (2.5) 5 (4.3) 1 (1.3)
Histologic grade 0.095 0.35 0.454
 I/II 10 (11.4) 9 (8.4) 6 (17.6) 13 (8.2) 11 (10.8) 8 (12.1)
 III 70 (79.5) 79 (73.8) 27 (79.4) 120 (75.5) 91 (89.2) 57 (86.4)
 Unknown 8 (9.1) 19 (17.8) 1 (2.9) 26 (16.4) 15 (12.8) 13 (16.7)
Nuclear grade 0.076 0.425 0.385
 I/II 23 (26.1) 13 (12.1) 8 (24.2) 28 (21.1) 25 (24.5) 11 (16.9)
 III 57 (64.8) 75 (70.1) 25 (75.8) 105 (78.9) 77 (75.5) 54 (83.1)
 Unknown 8 (9.1) 19 (17.8) 1 (2.9) 26 (16.4) 15 (12.8) 13 (16.7)

*Mean±SD; Entered as continuous variable.